On his official blog, businessman Clay Siegall posts about the latest sports and science news. A recent article is about the running back Jeremy Hill tweeting his goodbye to his now former teammates on the Cincinnati Bengals. He will become a free agent and sign with some other team is his plan. He is an unrestricted agent and said that not re-signing with the Bengals was a business decision on his part.
In science news, Clay Siegall posted an article that reveals that orca whales are able to imitate human speech. A group of researchers performed experiments with two orca whales who are held in a French aquarium. Some of the sounds they heard from the orcas were both “hello” and “bye-bye”. The whales also imitated people blowing a raspberry. Because the orcas also learned sounds from each other the research suggests that orca whales out in the wild also teach each other their language.
Clay Siegall is one of the founders of Seattle Genetics, Inc. It was established in 1998 and today he is this firm’s president, CEO, and chairman. He is also a director and board member of three other biopharmaceutical companies, Alder Biopharmaceuticals, Inc., Mirna Therapeutics, Inc., and Ultragenyx Pharmaceutical. He is also involved in a member of professional organizations such as the Washington Biotechnology and Biomedical Association, for which he is a director, and the Fred Hutchinson Cancer Research Business Alliance for which he has a seat on the board of governors.
As a prominent cancer researcher and drug developer, Clay Siegall has written 67 peer-reviewed research papers and also has nine patents. He also serves three peer-reviewed scientific journals by being on their editorial board. Additionally, he serves the Scientific Counselors for the Cancer Treatment Research Foundation as one of its board members.
Clay Siegall has been honored a number of times for his work to cure cancer. In 1995, while he was working for Bristol-Meyers Squibb, he was honored with the Pierce Award. This was given for his work in the field of targeted toxins. In 2002 he was honored to be a finalist for the Ernst & Young Pacific Northwest Entrepreneur of the Year.